register

Digital & Innovation

Public-private partnership to enhance ‘data driven medicine’ in cancer care

Health Industry Hub | November 11, 2022 |

Digital & Innovation: A ground-breaking initiative will give researchers access to de-identified, highly secure, compatible and robust data in a consolidated and meaningful manner to enable faster translation into clinical practice.

Peter MacCallum Cancer Centre is set to further enhance its position as a world-leading cancer centre through a Digital Health Cooperative Research Centre (DHCRC) project to trial an end-to-end digital platform from Max Kelsen, a Brisbane-based artificial intelligence (AI) and machine leaning (ML) company.

The project, coordinated by the Digital Health CRC and the platform, one of the first of its kind in Australia, will enable an aggregation of previously disparate and siloed data sets, spanning each patient’s diagnosis, treatment and post treatment journey. Swinburne University of Technology is the research partner for the three-year project.

Associate Professor Kate Burbury, Director of Digital and Healthcare Innovations at Peter Mac, said the unique collaboration across academia, healthcare and commercial organisations represents a potentially transformative digital healthcare project.

“The goal of this exciting project is to integrate Peter Mac’s digital data and better understand the benefits that can come from unlocking large health datasets to support collaborative digital health research,” Associate Professor Burbury said.

“We also hope it will assist with establishing a pipeline for the development of regulated, scalable and transferable Software as a Medical Device (SaMD). We see significant opportunity for this project to improve clinician decision-making, patient outcomes and drive long term digital health product development and commercialisation,” she said.

Nicholas Therkelsen-Terry, Max Kelsen CEO, said the concept of “data driven medicine” has the potential to improve and accelerate patient focused decision making, but before the application of AI, the task has been difficult because of the sheer size and complexity of siloed, clinical data sets and a reluctance of organisations to share them.

“Despite the best intentions of many stakeholders in healthcare and regulation, developing patient based innovation around data has been costly, time consuming and challenging from a regulatory perspective. With this project we are aiming to make it much simpler for researchers to access data which will allow them to build and deploy new innovations in clinical practice under the appropriate regulations – and do this faster and more cost-effectively through the application of game changing AI models,” Mr Therkelsen-Terry said.

“With ethically applied AI and technological innovation in medicine, we can make significant improvements to how healthcare is delivered in Australia and beyond, while ensuring innovation is regulatory approved,” Mr Therkelsen-Terry added.

“By creating a unique and applied data platform for the consolidation of important data, we can help medical practitioners deliver better and more personalised care.”

The Max Kelsen platform uniquely ensures data is shared securely with access to data contained within the platform and maintains privacy through de-identification of all health records. It also meets all regulatory and governance standards through a universal consent approach that gives patient control over how their data is shared.

Professor Christopher Fluke from Swinburne University of Technology said from a research perspective this initiative presents a unique opportunity to bring a deep and diverse data set together on one scalable platform.

“There is an ever-growing breadth of medical data but its form and disparity can make it difficult to use to drive tangible research outcomes. This project will enable us to observe the ethical and risk considerations of using such a large and inclusive data set in practice and observe how data and AI can help improve and enhance decision making outcomes for clinicians and patients.”

Dr Stefan Harrer, Digital Health CRC Chief Innovation Officer, said uniting these partners represented a long-term opportunity that has the potential to transform how digital health data is stored and shared.

“This project will initially integrate a novel, scalable data linkage and management platform into Peter Mac’s digital infrastructure and then use it to develop a production-grade AI-powered image segmentation module for potential inclusion in clinical workflows,” Dr Harrer said.

“This will set a precedent for empowering clinical institutions to tap into the abundance of health data they hold in highly efficient ways and to deliver real value to patients in trusted and personalised ways.”

“Given the unstructured and fragmented nature of health data and its exponentially growing size, AI is poised to play a key role for analysing it. This comes with challenges. In order to gain regulatory approval and the trust of clinician users and patients, AI algorithms need to be fair, transparent and robust,” Dr Harrer said.

“Secure data management systems linking different data sources and modalities together efficiently, privately and in an interoperable manner are a key ingredient for developing such responsible AI systems.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.